NCT06166953 The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled Study Status RECRUITING Phase NA
NCT06166173 Using Color Doppler US Artifact to Identify Tumor Markers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06165900 Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC Status RECRUITING Phase PHASE2
NCT06164119 Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal Therapy Status RECRUITING Phase NA
NCT06162663 Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors Status TERMINATED Phase PHASE4
NCT06162559 Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study Status RECRUITING Phase PHASE1
NCT06161792 Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer Status TERMINATED Phase PHASE2
NCT06161233 Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy Status COMPLETED Phase NA
NCT06158347 Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast Cancer Status COMPLETED Phase NA
NCT06156761 Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer Status NOT_YET_RECRUITING Phase NA
NCT06156397 The Effect of Technological Based Rehabilitation Practices After Breast Cancer Surgery Status COMPLETED Phase NA
NCT06155305 Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer Status RECRUITING Phase N/A
NCT06151639 Comparison of The Effects Of General Anesthesia and PECS Block Methods on Blood Counts in Patients With Breast Cancer Status COMPLETED Phase N/A
NCT06149377 Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer Status COMPLETED Phase N/A
NCT06149130 Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer Status RECRUITING Phase PHASE2
NCT06145399 A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer Status WITHDRAWN Phase EARLY_PHASE1